Paul Elliot Mann - Net Worth and Insider Trading
Paul Elliot Mann Net Worth
The estimated net worth of Paul Elliot Mann is at least $1,863 dollars as of 2025-01-12. Paul Elliot Mann is the CFO of Regenetp Inc and owns about 16,638 shares of Regenetp Inc (RGTPQ) stock worth over $1,863. Paul Elliot Mann is also the Director of Abeona Therapeutics Inc and owns about 0 shares of Abeona Therapeutics Inc (ABEO) stock worth over $0. Details can be seen in Paul Elliot Mann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Elliot Mann has not made any transactions after 2021-02-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Elliot Mann
Paul Elliot Mann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Elliot Mann owns 4 companies in total, including Abeona Therapeutics Inc (ABEO) , Regenetp Inc (RGTPQ) , and Healthtech Solutions Inc (HLTT) among others .
Click here to see the complete history of Paul Elliot Mann’s form 4 insider trades.
Insider Ownership Summary of Paul Elliot Mann
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ABEO | Abeona Therapeutics Inc | 2021-02-19 | director |
RGTPQ | Regenetp Inc | 2020-03-31 | Chief Financial Officer |
HLTT | Healthtech Solutions Inc | 2021-07-13 | director |
2022-11-09 | director & 10 percent owner & Chief Executive Officer |
Paul Elliot Mann Latest Holdings Summary
Paul Elliot Mann currently owns a total of 2 stocks. Among these stocks, Paul Elliot Mann owns 16,638 shares of Regenetp Inc (RGTPQ) as of March 31, 2020, with a value of $1,863 and a weighting of 100%. Paul Elliot Mann also owns 0 shares of Abeona Therapeutics Inc (ABEO) as of February 19, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Paul Elliot Mann
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RGTPQ | Regenetp Inc | 2020-03-31 | 16,638 | 0.11 | 1,863 |
ABEO | Abeona Therapeutics Inc | 2021-02-19 | 0 | 5.55 | 0 |
Holding Weightings of Paul Elliot Mann
Paul Elliot Mann Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Elliot Mann has made a total of 3 transactions in Regenetp Inc (RGTPQ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Regenetp Inc is the sale of 926 shares on March 31, 2020, which brought Paul Elliot Mann around $24,084.
According to the SEC Form 4 filings, Paul Elliot Mann has made a total of 6 transactions in Abeona Therapeutics Inc (ABEO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Abeona Therapeutics Inc is the sale of 1,823 shares on February 19, 2021, which brought Paul Elliot Mann around $108,447.
Insider Trading History of Paul Elliot Mann
- 1
Paul Elliot Mann Trading Performance
GuruFocus tracks the stock performance after each of Paul Elliot Mann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Elliot Mann is -26.94%. GuruFocus also compares Paul Elliot Mann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Elliot Mann within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Elliot Mann's insider trading performs compared to the benchmark.
Performance of Paul Elliot Mann
Paul Elliot Mann Ownership Network
Ownership Network List of Paul Elliot Mann
Ownership Network Relation of Paul Elliot Mann
Paul Elliot Mann Owned Company Details
What does Abeona Therapeutics Inc do?
Who are the key executives at Abeona Therapeutics Inc?
Paul Elliot Mann is the director of Abeona Therapeutics Inc. Other key executives at Abeona Therapeutics Inc include Chief Financial Officer Christine Berni Silverstein , SVP & General Counsel Brendan M. O'malley , and director & Chief Executive Officer Vishwas Seshadri .
Abeona Therapeutics Inc (ABEO) Insider Trades Summary
Over the past 18 months, Paul Elliot Mann made no insider transaction in Abeona Therapeutics Inc (ABEO). Other recent insider transactions involving Abeona Therapeutics Inc (ABEO) include a net purchase of 50,000 shares made by Vishwas Seshadri , a net sale of 39,290 shares made by Mark Alvino , and a net sale of 32,151 shares made by Christine Berni Silverstein .
In summary, during the past 3 months, insiders sold 0 shares of Abeona Therapeutics Inc (ABEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 92,852 shares of Abeona Therapeutics Inc (ABEO) were sold and 88,758 shares were bought by its insiders, resulting in a net sale of 4,094 shares.
Abeona Therapeutics Inc (ABEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Abeona Therapeutics Inc Insider Transactions
Paul Elliot Mann Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Elliot Mann. You might contact Paul Elliot Mann via mailing address: C/o Asp Isotopes Inc., 433 Plaza Real, Suite 275, Boca Raton Fl 33432.